Site Search

Search market news

Find public news by keyword, exact ticker, category and date.

News by ticker →AAPL news SPY news Earnings

News Feed

2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.

News 2026-10-14 11:30 UTC

Arrowhead Pharmaceuticals Announces ARO — MAPT Interim Phase 1/2a Clinical Data Demonstrating Deep and Durable Tau Reductions in Healthy Volunteers

For best results when printing this announcement, please click on link below: Arrowhead Pharmaceuticals Announces ARO-MAPT Interim Phase 1/2a Clinical Data Demonstrating Deep and Durable Tau Reductions in Healthy Volunteers Arrowhead’s TRiM(™) platform achieves clinical validation for delivery of siRNA that crosses the

ARWR.O

News 2026-10-14 11:30 UTC

Arrowhead Reports Up to 85% CSF Tau Reduction in Phase 1/2a

Interim data showed subcutaneous ARO-MAPT reduced CSF total tau by a mean of up to 73% at Day 105, with a maximum reduction of 85%, in healthy volunteers. The drug was generally well tolerated.

ARWR

Search market news

Matching instruments

Arrowhead Pharmaceuticals Announces ARO — MAPT Interim Phase 1/2a Clinical Data Demonstrating Deep and Durable Tau Reductions in Healthy Volunteers

Arrowhead Reports Up to 85% CSF Tau Reduction in Phase 1/2a